Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Change in Cash (2019 - 2025)

Harmony Biosciences Holdings' Change in Cash history spans 7 years, with the latest figure at $105.5 million for Q4 2025.

  • On a quarterly basis, Change in Cash rose 60.74% to $105.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $299.5 million, a 111.9% increase, with the full-year FY2025 number at $299.5 million, up 111.9% from a year prior.
  • Change in Cash hit $105.5 million in Q4 2025 for Harmony Biosciences Holdings, up from $100.9 million in the prior quarter.
  • Over the last five years, Change in Cash for HRMY hit a ceiling of $105.5 million in Q4 2025 and a floor of -$87.5 million in Q1 2021.
  • Historically, Change in Cash has averaged $26.2 million across 5 years, with a median of $26.9 million in 2022.
  • Biggest five-year swings in Change in Cash: crashed 285.85% in 2021 and later skyrocketed 874.83% in 2024.
  • Tracing HRMY's Change in Cash over 5 years: stood at $44.6 million in 2021, then plummeted by 139.37% to -$17.6 million in 2022, then grew by 26.4% to -$12.9 million in 2023, then surged by 607.89% to $65.6 million in 2024, then skyrocketed by 60.74% to $105.5 million in 2025.
  • Business Quant data shows Change in Cash for HRMY at $105.5 million in Q4 2025, $100.9 million in Q3 2025, and $57.1 million in Q2 2025.